⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21455543 | 0.97 | HDAC8 (0.54) | — | |
| Hydrochloric Acid SCHEMBL4434325 | 0.97 | HDAC8 (0.48) | — | |
| Hydrochloric Acid SCHEMBL21585662 | 0.97 | — | — | |
| SCHEMBL21441786 | 0.95 | HDAC8 (0.58) | — | |
| SCHEMBL26188318 | 0.95 | HDAC8 (0.58) | — | |
| SCHEMBL23458806 | 0.94 | HDAC8 (0.56) | — | |
| SCHEMBL923125 | 0.94 | — | — | |
| SCHEMBL14823812 | 0.92 | HDAC8 (0.61) | — | |
| SCHEMBL293980 | 0.92 | HDAC8 (0.61) | — | |
| SCHEMBL5520084 | 0.92 | HDAC8 (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3802501-B1 | COMPOUNDS AS NUCLEAR TRANSPORT MODULATORS AND USES THEREOF | XWPHARMA LTD (KY) | 2024-02-28 | — | — | EP | claimed |
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PSOMAGEN, INC. (US) | 2022-08-23 | — | — | US | claimed |
| US-20210128498-A1 | TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE | MACROGEN INC. (KR) | 2021-05-06 | — | — | US | claimed |
| EP-3668494-A1 | TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE | Psomagen, Inc. (US) | 2020-06-24 | — | — | EP | claimed |
| CN-111163761-A | Targeted drugs related to trimethylamine and/or trimethylamine-N-oxide | 普梭梅根公司 | 2020-05-15 | — | — | CN | claimed |
| WO-2019036507-A1 | TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE | uBiome, Inc. (US) | 2019-02-21 | — | — | WO | claimed |
| US-20190050525-A1 | RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES | PSOMAGEN, INC. | 2019-02-14 | — | — | US | claimed |
| JP-3698699-B2 | — | — | 2005-09-21 | — | — | JP | claimed |
| US-20040106724-A1 | Natural rubber produced from latex and composition comprising the same | BRIDGESTONE CORPORATION (JP) | 2004-06-03 | — | — | US | claimed |
| JP-2004514009-A | — | — | 2004-05-13 | — | — | JP | claimed |
| EP-1332161-A2 | DRYING PROCESSES FOR NATURAL RUBBER, STABILIZED NR COMPOSITIONS | Bridgestone Corporation (JP) | 2003-08-06 | — | — | EP | claimed |
| WO-2002038667-A2 | NATURAL RUBBER PRODUCED FROM LATEX AND COMPOSITION COMPRISING THE SAME | BRIDGESTONE CORPORATION (JP) | 2002-05-16 | — | — | WO | claimed |
| US-12637430-B2 | Interleukin-17 (IL-17) inhibitors | HITGEN INC. (CN) | 2026-05-26 | — | — | US | disclosed |
| EP-4177249-B1 | IMMUNOMODULATOR | HITGEN INC (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4638436-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-12338243-B2 | P2X7 modulators | JANSSEN PHARMACEUTICA NV (BE) | 2025-06-24 | — | — | US | disclosed |
| EP-0218689-A1 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS. | UPJOHN CO (US) | 1987-04-22 | — | — | EP | disclosed |
| EP-0214158-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1987-03-18 | — | — | EP | disclosed |
| WO-1986005982-A2 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | UPJOHN CO (US) | 1986-10-23 | — | — | WO | disclosed |
| WO-1986004582-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1986-08-14 | — | — | WO | disclosed |